IGI Logo

Aarti Drugs is currently trading at Rs. 463.00, up by 6.50 points or 1.42% from its previous closing of Rs. 456.50 on the BSE.

The scrip opened at Rs. 459.00 and has touched a high and low of Rs. 464.15 and Rs. 457.00 respectively. So far 304 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 634.90 on 27-Aug-2024 and a 52 week low of Rs. 430.00 on 28-Mar-2024.

Last one week high and low of the scrip stood at Rs. 464.15 and Rs. 441.00 respectively. The current market cap of the company is Rs. 4166.48 crore.

The promoters holding in the company stood at 55.64%, while Institutions and Non-Institutions held 10.34% and 34.02% respectively.

Aarti Drugs’ subsidiary -- Pinnacle Chile SpA has incorporated an overseas wholly owned subsidiary in the name of Pharma Go SpA for marketing the formulation drugs and participating in tender and private market in Chile. Its business is in line with the business of its holding companies. The newly incorporated company i.e. Pharma Go SpA becomes a step-down subsidiary of the Aarti Drugs.

Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.